Kristina Whitfield 
Introduction Gene editing has been featured prominently in the news recently. With studies published in Nature and Science, describing the advancement of sophisticated gene editing tools known as base editors. While the article in Nature details further development on the powerful CRISPR technology for editing DNA, the publication in Science presents a highly promising RNA … Read more
Pivotal Scientific: Industry Insights German manufacturer PROGEN has launched a truly novel validation program that utilizes the peptide mapping technology ofits collaborator PEPperPRINT As ever, in this fast moving sector, there’s a lot to consider and think about, and so we’ve looked briefly at just a few things we’ve picked up on. Where people are … Read more
Introduction The Government’s industrial strategy green paper was launched in January, with the aim of addressing long-term challenges to the UK economy. It identified the life sciences industry as a dominant economic sector within the UK, generating approximately £64 billion of turnover, employing >200,000 scientists and staff, and providing an exceptional environment for businesses to … Read more
Introduction As many western companies travel through Europe and the US to attend important events like AACC/ASCB|EMBO/MEDICA, it is usually quite productive to promote your brand through booth display or find business opportunities at these occasions. Accordingly, many important conferences/exhibitions are held in China every year and these could be great opportunities for international brands … Read more
Introduction As we all know there is a great deal of in the Biological sector of the Chinese market however there could be some unexpected obstacles to gain profit in this unique market. The first frequent problem is in exporting to the Chinese market. According to the regulations in importing/exporting in China, the inspection and … Read more
Introduction This month we’ve picked a somewhat broad topic for the blog: The future of suppliers of research. What are the things that should be on the mind of the forward-thinking supplier of research use only reagents? Of course, this is largely and necessarily speculation, but hopefully somewhat informed! There are two general, interlinked areas … Read more
Introduction Among all the ligand bioassays developed, the one which has emerged victorious is the Enzyme Linked Immuno Assay, or ELISA. Variations of the ELISA now have to power to discriminate antigens down to the femtomole/femtogramme (10-18 of a kilogramme) level, depending on how it’s implemented, offering researchers unprecedented levels of sensitivity. Furthermore, ELISA could harness … Read more
Introduction The EU General Data Protection Regulation (GDPR) replaces the Data Protection Directive 95/46/EC in May 2018. Should we be concerned as businesses? I personally do not think that we need to be concerned but we should be prepared. So here are my thoughts on the pending change and how we may be able to prepare ourselves. Arguably … Read more
Introduction ‘Small molecules’ (SMs) are a diverse set of organic molecules that can be hard to pin down more specifically. In life sciences research, what we usually mean is bioactive small molecules, with a mass no more than about one kilodalton. Scientists can use these small molecules to activate or inhibit some biological function or property. The … Read more
Introduction Many international companies find that the Chinese research reagent market seems to be quite different than that in US or Europe. In the first years of entry to the market, it is quite difficult to analyze the potential, customer behavior and effective strategy for growth. Usually, it is easier to boost the sales with the … Read more